Chat with us, powered by LiveChat
Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market     Drug formulations     ATC     Antiinfectives for Systemic Use     Vaccines     Animal Vaccines     Sub-unit vaccines    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asian Sub-unit vaccines Market Research Report

  • Report Code: SU 1002
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The Asian Sub-unit Animal Vaccine Market is mainly driven by growing prevalence of animal diseases and increasing incidences of Zoonotic Diseases in Humans. This market was valued at $15 million in 2013 and is expected to reach $27 million by 2018, at a CAGR of 12.2%.

 

 “The Asian Sub-unit Animal Vaccine Market, 2012-2018” analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. Sub-unit vaccines contain one or more antigens as an alternative instead of the entire microbe. These vaccines usually cost more than Live Attenuated vaccines (LAVs) and inactivated vaccines because of high research costs.

 

Some examples of Sub-unit vaccines are the Genetivac brand of Feline Leukemia Vaccine, OspA—a purified Sub-unit protein vaccine and Porcilis APP.

 

Asian countries are potential markets for the animal vaccines market with a huge number of domesticated animals, such as dogs, chicken, cattle, and pigs. The animal vaccines market in the Asian region has changed remarkably over the past few years and will continue to grow, considering the increase in the numbers of people adopting pets, especially in India and China.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The main companies are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.

 

 Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

 

 

 

 

Customization Options:

Along with the market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (Segment wise)
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
  • End-user Adoption rate analysis of the products (Segment wise and Country wise)
  • Comprehensive coverage of Product approvals, Pipeline products and Product recalls

 

Epidemiology Data

  • Country specific Prevalence of Feline leukemia virus and Pleuropneumonia
  • Country specific Patient pool Feline leukemia virus and Pleuropneumonia
  • Disease progression (Pattern analysis)

 

Surgeons/Physicians Perception Analysis

  • Fast turn-around analysis of Surgeons response to market events and trends
  • Pattern analysis of usage of Sub-unit vaccines by Physicians
  • Surgeons’ opinion about products from different companies
  • Surgeons’ qualitative inputs on epidemiology data

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

 

Competitive Intelligence

  • The company share analysis of Asian Sub-unit Animal Vaccine Market for the top players of the market in the region.
  • The crucial developments and strategies of companies creating their portfolio for Asian Sub-unit Animal Vaccine Market.


1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Sub-unit vaccines-Asia, By Types
4.1 Split By Geography
4.1 Sub-unit vaccines-Asia - Other Geographies by Types
4.1 Sub-unit vaccines-Asia - Japan by Types
4.1 Sub-unit vaccines-China by Types
4.1 Sub-unit vaccines-India by Types
4.2 Sub-unit vaccines-Preventive-Asia
4.2.1 Sub-unit vaccines-Preventive-Asia, By Geographies
4.2.1.1 Sub-unit vaccines-Preventive-Asia - Japan
4.2.1.2 Sub-unit vaccines-Preventive-China
4.2.1.3 Sub-unit vaccines-Preventive-India
4.2.1.4 Sub-unit vaccines-Preventive-Asia - Other Geographies
4.3 Sub-unit vaccines-Therapeutic-Asia
4.3.1 Sub-unit vaccines-Therapeutic-Asia, By Geographies
4.3.1.1 Sub-unit vaccines-Therapeutic-Asia - Japan
4.3.1.2 Sub-unit vaccines-Therapeutic-China
4.3.1.3 Sub-unit vaccines-Therapeutic-India
4.3.1.4 Sub-unit vaccines-Therapeutic-Asia - Other Geographies
5 Sub-unit vaccines-Asia, By Geographies
5.1 Sub-unit vaccines-Asia - Other Geographies
5.1.1 Sub-unit vaccines-Asia - Other Geographies, By Types
5.1.1.1 Sub-unit vaccines-Preventive-Asia - Other Geographies
5.1.1.2 Sub-unit vaccines-Therapeutic-Asia - Other Geographies
5.2 Sub-unit vaccines-Asia - Japan
5.2.1 Sub-unit vaccines-Asia - Japan, By Types
5.2.1.1 Sub-unit vaccines-Preventive-Asia - Japan
5.2.1.2 Sub-unit vaccines-Therapeutic-Asia - Japan
5.3 Sub-unit vaccines-China
5.3.1 Sub-unit vaccines-China, By Types
5.3.1.1 Sub-unit vaccines-Preventive-China
5.3.1.2 Sub-unit vaccines-Therapeutic-China
5.4 Sub-unit vaccines-India
5.4.1 Sub-unit vaccines-India, By Types
5.4.1.1 Sub-unit vaccines-Preventive-India
5.4.1.2 Sub-unit vaccines-Therapeutic-India
6 Sub-unit vaccines-Asia, By Companies
6.1 Competitive landscape
6.2 Split By Geography
6.2 Sub-unit vaccines-Asia - Other Geographies by Companies
6.1 Sub-unit vaccines-Asia - Japan by Companies
6.1 Sub-unit vaccines-China by Companies
6.1 Sub-unit vaccines-India by Companies
6.3 Sub-unit vaccines-Asia-Other Companies
6.4 Sub-unit vaccines-Asia-Pfizer Inc
6.5 Sub-unit vaccines-Asia-Merck & Co., Inc.
6.6 Sub-unit vaccines-Asia-Sanofi-Aventis U.S.
6.7 Sub-unit vaccines-Asia-Bayer Healthcare
6.8 Sub-unit vaccines-Asia-Virbac

Please fill in the form below to receive a free copy of the Summary of this Report
















Asian Sub-unit vaccines Market Research Report

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Connect With Us
US/CAN : +1-888-502-0539